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Open access under the ElsThe therapeutic effects of praziquantel (PZQ) against a Schistosoma mansoni isolate derived from Nectomys
squamipes (isolate R) and a susceptible isolate (BH) were analyzed in Swiss mice by fecal egg counting,
adult worm reduction and oogram pattern. Infected mice were orally administrated with 62.5 mg/kg
(group 1), 125 mg/kg (group 2), 250 mg/kg (group 3) and 500 mg/kg (group 4), each dose divided over
3 days (49, 50 and 51 days after infection). The data were analyzed using one-way analysis of variance
(ANOVA). In regard to isolate R, no fecal eggs were observed with 250 mg/Kg and 500 mg/kg (p < 0.05),
whereas BH excretion reached zero with all doses. Mean worm burden reduction was signiﬁcantly
(p < 0.05) higher at the two highest concentrations, regardless of isolate. At 62.5 mg/kg, the percentage
of immature eggs varied from 17% (isolate R) to 38% (isolate BH). At 125 mg/kg, the percentage of immature
eggs varied from 20% (isolate R) to 16% (isolate BH). At 250 mg/kg, immature eggs dropped signiﬁcantly to
1% (isolate R) and 4% (isolate BH). At 500 mg/kg, no immature eggs were found in isolate R, whereas in BH
was 8%. No dosage signiﬁcantly (p > 0.05) affected the percentage of mature eggs, regardless of isolate.
There was a large increase (p < 0.001) in the percentages of dead eggs in all treated groups of 62% and
64% in groups 3 and 4, respectively (isolate R). The percentage of dead eggs rose from 34% (group 1) to
58% (group 3) in isolate BH. Although group 4 showed lowest increase in the percentage of dead eggs
(46%), it was higher (p < 0.001) compared to the 8% in the control. Our ﬁndings indicate that the wild isolate
from N. squamipes is susceptible to PZQ.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Human schistosomiasis mansoni, caused by the blood dwelling
ﬂuke Schistosoma mansoni, is one of the most widespread neglected
tropical water-borne diseases (Chitsulo et al., 2000), because
inhabitants in these regions have frequent contact with contami-
nated water (Sarvel et al., 2011).
Although S.mansoni is primarily a parasite of humans, other prima-
tes (Nelson, 1960; Standley et al., 2011), bovines (Barbosa et al., 1962;
Modena et al., 2008) and rodents can serve as reservoir hosts (Théron
et al., 1992; Alarcón de Noya et al., 1997). In Brazil, six aspects pertain-
ing to the importance of Nectomys squamipes (water rat) in schistoso-
miasis transmission should be highlighted: (i) this species is semi-
aquatic; (ii) its wide geographic range sometimes is coincident with
S. mansoni-endemic areas (Bonvicino et al., 2002; D’Andrea et al.,onado-Júnior).
) fellow.
evier OA license.2002); (iii) fecal sample examination shows steady release of viable
eggs (Antunes et al., 1973; Silva et al., 1992; Maldonado et al., 1994)
for 14 weeks after experimental infection (Souza et al., 1992); (iv)
experimental studies show the susceptibility to several laboratory-
bred S. mansoni stocks (Martinez et al., 2008); (v) neither natural nor
experimental infections excessively threaten the life span and
reproductive capacity of this rat (D’Andrea et al., 2000); and (vi) the
existence of N. squamipes naturally infected by S. mansoni is a
drawback for schistosomiasis control programs (Rey, 1993).
The possible methods available to control schistosomiasis have
long been recognized as being improved water supply, implemen-
tation of basic sanitationmeasures, improvement of socioeconomic
conditions, snail control and chemotherapy for human infections
(WHO, 1993). In addition, the Chinese control program against
schistosomiasis selected treatment of animal hosts (bovines) with
praziquantel (PZQ) (Chen, 2005). PZQ (2-cyclohexylcarbonyl-
1,2,3,6,7,11b-hexahydro-4H-pyrazino{2,1-a}isoquinoline-4-one) is
the drug of choice for both public health campaigns and clinical
use (Moreira et al., 2007).
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that the cure rate can reach 85–90% (Doenhoff et al., 2009). Labo-
ratory studies have demonstrated that mice sex, strain and worm
burden do not inﬂuence efﬁcacy rates (Gonnert and Andrews,
1977). Experimental studies have investigated the antischistoso-
mal activity of PZQ on schistosomes derived from humans (Araújo
et al., 1996; Fallon and Doenhoff, 1994). However, to our knowl-
edge the susceptibility of isolates derived from wild rodents has
not been investigated.2. Material and methods
2.1. Fieldwork area
The ﬁeldwork was conducted in the municipality of Sumidouro
(220204600S; 424102100W), a rural area of the Atlantic Forest situ-
ated in Rio de Janeiro state (Brazil). In this area, N. squamipes is
the main non-human host of S. mansoni (Silva et al., 1992) and
its levels of infection do not change even if the human population
is treated with anti-schistosome drugs (D’Andrea et al., 2000).
The region has a humid-mesothermic climate; rainfall is sea-
sonal and heaviest between November and March, whereas the
dry months generally extend from May to August (D’Andrea
et al., 2000). The capture sites were established along watercourses
and ﬂooded areas, according to the semi-aquatic habits of N.
squamipes (D’Andrea et al., 2007). Fecal samples were collected
from every trapped rat. To conﬁrm infection, fecal samples were
prepared on slides and microscopically examined, using the
Kato-Katz smear technique (Katz et al., 1972). The miracidia ob-
tained from eggs in positive fecal samples from three N. squamipes
(isolate R) were used to infect laboratory-bred Biomphalaria
glabrata snails.2.2. Ethical approval
All animal experiments were conducted in accordance with va-
lid international guidelines for animal experimentation (Ellery,
1985) and were in accordance with the ethical rules of the Oswaldo
Cruz Foundation Animal Ethics Committee (L-0017/08) and
Brazilian Institute of the Environment and Renewable Natural
Resources (IBAMA License No. 02001.000384/00-12).2.3. Mice and parasites
Swiss Webster (SW) mice were housed under standard caging
conditions: polypropylene boxes (40  33 cm) with stainless steel
screened covers in a room with controlled temperature
(25 ± 1 C) and humidity (60 ± 10%) and artiﬁcial dark/light cycle
(lights on from 07:00 to 19:00). The animals had free access to
water and food (Nuvilab CR-1, Paraná, Brazil).2.4. Life-cycle maintenance
Cercariae of S. mansoni (isolate R) were obtained from infected
B. glabrata snails following exposure to artiﬁcial light to induce
cercariae shedding in our laboratory, while isolate BH was main-
tained in the Malacology Laboratory (Oswaldo Cruz Institute, Rio
de Janeiro, Brazil), also using B. glabrata snails and SW mice as
intermediate hosts, respectively (Paraense and Corrêa, 1981).
The procedures for experimental infections have been described
previously (Freire et al., 2003). Brieﬂy, female and male mice
(n = 28) were subcutaneously infected with 50 cercariae (isolate
R), while the control mice (n = 25) were exposed to isolate BH, sus-
ceptible to praziquantel (Drescher et al., 1993).2.5. Treatment schedule
The mice were given praziquantel (Merck) dissolved in 2%
cremophor-EL (Sigma, Chemical Company, St. Louis, USA) by
gastric gavage at total dosages of 62.5, 125, 250 and 500 mg/kg)
each dose divided over 3 days (49, 50 and 51 days after infection)
(Sabah et al., 1986). Infected untreated mice remained as control
group.
2.6. Assessment of the therapeutic effects
2.6.1. Worm burden determination
Two weeks after treatment, the mice from both isolates were
euthanized using a CO2 chamber. Adult worms recovered by
hepatic and mesenteric perfusion were counted and sexed under
a stereomicroscope (Smithers and Terry, 1965). The worm burden
(infectivity) was determined as the percentage of maturation of
cercariae into adult worms recovered from the portal system and
mesenteric veins (Freire et al., 2003). The percentage reduction of
worm burden in each drug treated group (Cioli et al., 2004) was
calculated according to the following equation:
Reduction ð%Þ
¼No: of worms in control groupNo: of worms in treated groupÞðNo: of worms in control groupÞ 100
The mean of worm reduction related for each isolate PZQ dose
was calculated and then the effective dose required to kill 50% of
the worms (ED50) was estimated. Data were analyzed using Graph-
Pad Prism 4 computer software using the sigmoidal curve, with 5%
signiﬁcance.
2.6.2. Parasitological studies
Stool pellets were collected weekly from the mice at 6 weeks
until euthanasia and microscopically examined to conﬁrm the
establishment of infection and fecal egg dynamics. Eggs per gram
of feces (epg) were determined in individual samples/animal/day,
using the Kato-Katz thick smear technique (Katz et al., 1972).
2.6.3. Egg developmental stages (oogram pattern)
The whole small intestine was removed from every mouse,
opened lengthwise and separated into two equal sections (proxi-
mal and distal). A sample (1 cm long) from the last section was ta-
ken and crushed between two glass slides to obtain a thin
preparation (Machado-Silva et al., 1991). The percentage of eggs
at various developmental stages (immature, mature and dead)
was determined by light microscopy (Pellegrino et al., 1962).
2.7. Statistical analysis
Data analysis was performed using the Graph Pad Instat statis-
tical program. Biological data were analyzed using one-way analy-
sis of variance (ANOVA). Measurements with p-values 60.05 were
considered signiﬁcantly different.3. Results
3.1. Fecal egg release
A similar kinetics of fecal egg elimination was detected for both
R and BH isolates (Fig. 1). Eggs were ﬁrst detected in the feces at
week 6, with mean numbers peaking between weeks 7 and 8
and declining thereafter, which was coincident with drug adminis-
tration. There was a dose-dependent decrease in fecal egg count.
Praziquantel was signiﬁcantly (p = 0.003) effective against isolate
R at a dose of 500 mg/kg, at which egg excretion reached zero
Fig. 1. Kinetics of egg elimination in stools after treatment with praziquantel (PZQ) administered at different dosages to Swiss Webster mice infected with (A) rodent (R) or
(B) Belo Horizonte (BH) isolates of Schistosoma mansoni.
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minated fecal egg output. Egg-laying from the corresponding un-
treated controls was signiﬁcantly higher (p < 0.001) than from
the treated group.
3.2. Worm burden reduction
Table 1 shows the worm burden reduction and oogram pattern
in relation to the dosage of praziquantel administered to the in-
fected mice. Untreated control mice infected with isolate R yielded
higher mean number (31 ± 4; 62%) than BH (25 ± 3; 50%). The data
on worm burden reduction revealed that treatment efﬁcacy was
dose-dependent. At low doses of 62.5 mg/kg, the mean worm bur-
den reduction and percentage were lower for both isolate R
(25 ± 4; 19%) and isolate BH (17 ± 5; 32%). When 125 mg/kg was
administered, the efﬁcacy against isolate R increased (23 ± 5;
26%), as it did against isolate BH (11 ± 2; 56%). The treatment efﬁ-
cacy was signiﬁcantly higher (p < 0.05) at the two highest prazi-
quantel concentrations tested: 250 mg/kg (9 ± 3; 71% and 6 ± 2;Table 1
Parasitological effects of different dosages of praziquantel against isolates (R and BH) of S
Parameters Groups
R isolate
Untreated 1 2 3 4
Worm recovery 31 ± 4 25 ± 4 23 ± 5 9 ± 3* 4
Male–female ratio 4:1 3:1 2:1 3:1 1
Worm reduction (%) – 19 26 71* 8
Oogram
Immature 32 ± 6 17 ± 2 20 ± 6 1 ± 0.5* 0
Mature 47 ± 5 48 ± 4# 38 ± 6 37 ± 7 3
Dead 21 ± 2# 35 ± 3 42 ± 6* 62 ± 7* 6
Groups: 1 (62.5 mg/kg), 2 (125 mg/kg), 3 (250 mg/kg), 4 (500 mg/kg).
Oogram (%): egg developmental stages.
* Signiﬁcant difference (p < 0.05) when compared with the respective untreated group.
# Signiﬁcant difference (p < 0.05) when compared between each dosage regarding BH a76%) and 500 mg/kg (4 ± 1; 87% and 1 ± 1; 96%), for isolate R and
BH, respectively.
The ED50 was higher in isolate R (181 mg/kg de PZQ) than iso-
late BH (105 mg/kg de PZQ).
It should be noted that treatment caused a dose-dependent
reduction in the male-female ratio only in isolate R. The male/fe-
male ratio decreased from 4:1 (untreated group) to 1:1 (group 4)
(Table 1).
3.3. Egg developmental stages
In the oogram assay, both treated and untreated mice presented
eggs at all stages of development, although therapeutic efﬁcacy
was dependent on the treatment schedule. At the lowest dose
(62.5 mg/kg) of PZQ, the percentage of immature eggs was 17%
(isolate R) and 38% (isolate BH). At the next higher dose (125 mg/
kg), isolate R showed a slight increasing in the percentage of
immature eggs (20%), whereas the rate for isolate BH declined from
38% to 16%. When 250 mg/kg was given, immature eggs droppedchistosoma mansoni harbored in mice.
BH isolate
Untreated 1 2 3 4
± 1* 25 ± 3 17 ± 5 11 ± 2* 6 ± 2* 1 ± 1*
:1 1:1 1:1 1:1 1:1 1:1
7* – 32 56* 76* 96*
* 39 ± 4 38 ± 15 16 ± 6 4 ± 2* 8 ± 4
6 ± 1 53 ± 4 28 ± 5# 47 ± 2 38 ± 13 46 ± 7
4 ± 1⁄# 8 ± 1# 34 ± 11 37 ± 4 58 ± 13* 46 ± 6⁄#
nd R isolate.
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dose tested (500 mg/Kg), no immature eggs were found in isolate
R, whereas in BH the rate was 8%.
As shown in Table 1, the percentage of mature eggs was less
than in the corresponding untreated control at 125, 250 and
500 mg/kg (isolate R). In regard to isolate BH, this percentage oc-
curred only at the lowest dosage. There was a sharp increase in
the percentages of dead eggs in all treated groups, with signiﬁcant
(p < 0.0001) increases to 62% and 64% in groups 3 and 4, respec-
tively (isolate R). The percentage of dead eggs rose from 34% (group
1) to 58% (group 3) in isolate BH. Although group 4 showed lowest
increase in the percentage of dead eggs, to 46%, it was signiﬁcantly
higher (p < 0.05) compared to the 8% in the control group (Table 1).
There was no correlation between the number of worms recov-
ered and the oogram pattern or fecal egg output.4. Discussion
PZQ has become the drug of choice for schistosomiasis due to its
effective pharmacological properties, lack of signiﬁcant toxicity and
relatively low cost (for a review, see Doenhoff et al., 2008). To our
knowledge, this is the ﬁrst study of the effects of PZQ against a nat-
urally occurring Brazilian rodent isolate of S. mansoni. Such investi-
gation is important because Sigmondontinae rodents act as
reservoirs of S. mansoni, which hampers schistosomiasis control
programs (Rey, 1993; Peralta et al., 2009). Another contribution of
this study is that the isolate used is derived from a region where
there is a positive correlation between the prevalence of infection
in the rodent and human populations (D’Andrea et al., 2000).
Obtaining an isolate from wild rodents in laboratory mice was
the ﬁrst step for further testing of its susceptibility to schistosomi-
cides. It is interesting that the isolate derived from N. squamipes
was adapted to SW mice based on the kinetics of fecal egg-output
and perfusion data, which revealed maturation between 56 and
60% at 8 weeks in the C3H/He mouse strain (Freire et al., 2003).
The gold standard for diagnosing schistosomiasis infection is
microscopic detection of eggs from stools. Moreover, changes in
patterns of schistosome egg elimination are mostly used to deter-
mine the drug’s effectiveness, in terms of a cure rate and/or egg
reduction rate (Doenhoff et al., 2008). Analysis of fecal samples
may not reveal eggs due to a number of factors, including the level
of infection, which inﬂuences the sensitivity limits of the examina-
tion technique (Berhe et al., 2004; Gonçalves et al., 2006). In this
study, aiming to improve the limitation of diagnosis, multiple fecal
examinations were performed (Wilson et al., 2006).
The examination of fecal material using the Kato-Katz thick
smear technique demonstrated an initial rise in the egg-output
by weeks 6–7, which declined after the mice were given PZQ. These
results are consistent with reports from other therapeutic assays
(Lescano et al., 2004).
Under laboratory conditions, this efﬁcacy against mature infec-
tion can also be assessed by worm burden reduction and oogram
changes (Pellegrino et al., 1977; Botros et al., 2004; Araújo et al.,
2008). It is worth mentioning that all dosages used here are in-
cluded as PZQ subcurative doses, while 600 mg/kg is a curative
one (Chaiworaporn et al., 2005). The praziquantel dosage protocols
in the present study caused a signiﬁcant worm burden reduction
and modiﬁcations in the oogram pattern, with the best efﬁcacy at-
tained with the highest dose (500 mg/kg).
In this study, PZQ was effective against isolate R and BH. Isolate
BH has been found to be sensitive to PZQ (Drescher et al., 1993).
Moreover, differences in susceptibility to PZQ have also been re-
ported among isolates of different geographic origin (Fallon et al.,
1997) and between long-maintained laboratory isolates and those
from natural human infections (Melman et al., 2009). A major con-sideration for such difference is that ﬁeld isolates from Brazil are
more diverse than long-maintained laboratory isolates (Rodrigues
et al., 2002). One potential explanation is that ﬁeld isolates decrease
variability due to loss of alleles after passage in murine hosts
(Loverde et al., 1985). The genetic bottleneck may be the reason
for such ﬁndings (Bech et al., 2010). The time lapse for each isolate
that has been maintained under laboratory conditions is probably
the underlying reason for such differences between isolates.
Our in vivo study showed a higher sensitivity of male worms
from isolate R, inferred from the male-female- ratio data, which
were male-biased (4:1, untreated group) and decreased to a 1:1
male/female ratio in mice exposed to a higher dosage (500 mg/
kg). Our ﬁnding support previous observations (Gonnert and
Andrews, 1977), but other studies have shown preferential killing
of female worms by PZQ (Delgado et al., 1992).
Examination of the oograms showed a lower percentage of
immature and mature eggs and a higher percentage of dead eggs
than in the control animals. Nevertheless, there are no doubts
about the effects of PZQ on adult worms (Doenhoff et al., 2008).
The effect of a double dose of PZQ on mature eggs has been re-
ported (Giboda and Smith, 1994). This is an important issue be-
cause only mature eggs can cross gut tissue to be excreted with
the host’s feces (Giboda and Smith, 1994). The possible explanation
is that high doses of PZQ could be acting on the reproductive sys-
tem of female worms. In this situation, eggs could display low
development capacity or the dosages used here were enough to
act on the mature eggs, as previously reported (Giboda and Smith,
1994). This impairment could lead to the death of the embryo
within the egg. Morphological studies to assess changes in the
reproductive system (Shaw and Erasmus, 1988; Neves et al.,
2004) of adult worms are ongoing. Interestingly, morphological
studies through scanning confocal laser microscopy for determina-
tion of egg viability (Holtfreter et al., 2011) and functional criteria
such as labeling the eggs with the Hoechst 33258 ﬂuorescent probe
(Sarvel et al., 2006) and intestine histopathology (Conceição et al.,
2008) can provide important information regarding this issue. Our
ﬁndings indicate that the wild isolate from N. squamipes is suscep-
tible to praziquantel. Although public health ofﬁcials consider the
best schistosomiasis control strategy to be treatment of the in-
fected human population, the epidemiologic signiﬁcance of the
presence of infected wild water rat hosts needs to be considered.
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